33257649|t|(D620N) VPS35 causes the impairment of Wnt/beta-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.
33257649|a|Patients with familial type 17 of Parkinson's disease (PARK17) manifest autosomal dominant pattern and late-onset parkinsonian syndromes. Heterozygous (D620N) mutation of vacuolar protein sorting 35 (VPS35) is genetic cause of PARK17. We prepared heterozygous VPS35D620N/+ knockin mouse, which is an ideal animal model of (D620N) VPS35-induced autosomal dominant PARK17. Late-onset loss of substantia nigra pars compacta (SNpc) dopaminergic (DAergic) neurons and motor deficits of Parkinson's disease were found in 16-month-old VPS35D620N/+ mice. Normal function of VPS35-containing retromer is needed for activity of Wnt/beta-catenin cascade, which participates in protection and survival of SNpc DAergic neurons. It was hypothesized that (D620N) VPS35 mutation causes the malfunction of VPS35 and resulting impaired activity of Wnt/beta-catenin pathway. Protein levels of Wnt1 and nuclear beta-catenin were reduced in SN of 16-month-old VPS35D620N/+ knockin mice. Downregulated protein expression of survivin, which is a target gene of nuclear beta-catenin, and upregulated protein levels of active caspase-8 and active caspase-9 were observed in SN of VPS35D620N/+ mice at age of 16 months. VPS35 is involved in controlling morphology and function of mitochondria. Impaired function of VPS35 caused by (D620N) mutation could lead to abnormal morphology and malfunction of mitochondria. A significant decrease in mitochondrial size and resulting mitochondrial fragmentation was found in tyrosine hydroxylase-positive and neuromelanin-positive SNpc DAergic neurons of 16-month-old VPS35D620N/+ mice. Mitochondrial complex I activity or complex IV activity was reduced in SN of 16-month-old VPS35D620N/+ mice. Increased level of mitochondrial ROS and oxidative stress were found in SN of 16-month-old VPS35D620N/+ mice. Levels of cytosolic cytochrome c and active caspase-3 were increased in SN of VPS35D620N/+ mice aged 16 months. Our results suggest that PARK17 mutant (D620N) VPS35 impairs activity of Wnt/beta-catenin signaling pathway and causes abnormal morphology and dysfunction of mitochondria, which could lead to neurodegeneration of SNpc DAergic cells.
33257649	1	6	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:9606;CA#:259758
33257649	8	13	VPS35	Gene	65114
33257649	43	55	beta-catenin	Gene	12387
33257649	124	129	mouse	Species	10090
33257649	137	145	Patients	Species	9606
33257649	151	190	familial type 17 of Parkinson's disease	Disease	OMIM:614203
33257649	192	198	PARK17	Disease	OMIM:614203
33257649	251	273	parkinsonian syndromes	Disease	MESH:D020734
33257649	289	294	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:9606;CA#:259758
33257649	308	335	vacuolar protein sorting 35	Gene	55737
33257649	337	342	VPS35	Gene	55737
33257649	364	370	PARK17	Disease	OMIM:614203
33257649	397	407	VPS35D620N	Chemical	-
33257649	418	423	mouse	Species	10090
33257649	460	465	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:9606;CA#:259758
33257649	467	472	VPS35	Gene	65114
33257649	600	614	motor deficits	Disease	MESH:D009461
33257649	618	637	Parkinson's disease	Disease	MESH:D010300
33257649	665	675	VPS35D620N	Chemical	-
33257649	678	682	mice	Species	10090
33257649	703	708	VPS35	Gene	65114
33257649	759	771	beta-catenin	Gene	12387
33257649	878	883	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:9606;CA#:259758
33257649	885	890	VPS35	Gene	65114
33257649	911	922	malfunction	Disease	
33257649	926	931	VPS35	Gene	65114
33257649	971	983	beta-catenin	Gene	12387
33257649	1011	1015	Wnt1	Gene	22408
33257649	1028	1040	beta-catenin	Gene	12387
33257649	1076	1086	VPS35D620N	Chemical	-
33257649	1097	1101	mice	Species	10090
33257649	1139	1147	survivin	Gene	11799
33257649	1183	1195	beta-catenin	Gene	12387
33257649	1238	1247	caspase-8	Gene	12370
33257649	1259	1268	caspase-9	Gene	12371
33257649	1305	1309	mice	Species	10090
33257649	1331	1336	VPS35	Gene	65114
33257649	1391	1403	mitochondria	Disease	MESH:C564971
33257649	1426	1431	VPS35	Gene	65114
33257649	1443	1448	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:9606;CA#:259758
33257649	1497	1508	malfunction	Disease	
33257649	1512	1524	mitochondria	Disease	MESH:C564971
33257649	1626	1646	tyrosine hydroxylase	Gene	21823
33257649	1660	1672	neuromelanin	Chemical	MESH:C014121
33257649	1719	1729	VPS35D620N	Chemical	-
33257649	1732	1736	mice	Species	10090
33257649	1828	1838	VPS35D620N	Chemical	-
33257649	1841	1845	mice	Species	10090
33257649	1880	1883	ROS	Chemical	-
33257649	1938	1948	VPS35D620N	Chemical	-
33257649	1951	1955	mice	Species	10090
33257649	2001	2010	caspase-3	Gene	12367
33257649	2035	2045	VPS35D620N	Chemical	-
33257649	2048	2052	mice	Species	10090
33257649	2109	2114	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:9606;CA#:259758
33257649	2116	2121	VPS35	Gene	65114
33257649	2146	2158	beta-catenin	Gene	12387
33257649	2227	2239	mitochondria	Disease	MESH:C564971
33257649	2261	2278	neurodegeneration	Disease	MESH:D019636
33257649	Association	MESH:C564971	RS#:188286943;HGVS:p.D620N;CorrespondingGene:55737
33257649	Association	MESH:D010300	12387
33257649	Association	OMIM:614203	65114
33257649	Positive_Correlation	OMIM:614203	RS#:188286943;HGVS:p.D620N;CorrespondingGene:55737
33257649	Association	12387	65114
33257649	Association	MESH:D019636	65114
33257649	Association	11799	12387
33257649	Association	12367	65114
33257649	Association	MESH:C564971	65114
33257649	Association	OMIM:614203	55737
33257649	Association	MESH:C564971	55737
33257649	Association	OMIM:614203	55737

